Riskpilot← Back to searchSign inGet full accessImmuneed AB
ABActiveOrg 5569744807Kungsgatan 70 DResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20145-9 employees
Revenue 2024
SEK 12,2M
-39% vs 2023
EBITDA margin
-63.9%
+12% vs 2023
Equity ratio
46.1%
Financial strength
Net profit 2024
SEK -8,3M
+12% vs 2023
| Revenue | SEK 12,2M | -39% |
| EBITDA | SEK -7,8M | +12% |
| Net profit | SEK -8,3M | +12% |
| Total assets | SEK 9,9M | -29% |
| Equity | SEK 4,5M | -10% |
| Employees | — | — |
Legal name
Immuneed AB
Org number
5569744807
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13 juni 2014
Share capital
SEK 284 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna eller en av dem i förening med Kele, Alexander Josef Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning och utveckling samt service- verksamhet inom biomedicin, medicin, immunologi och cancer och därmed förenlig verksamhet.
Address
Kungsgatan 70 D
Email
camilla.oldgren@immuneed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 6 098 | 7 005 | 9 834 | 12 957 | 22 149 | 19 902 | 12 186 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −374 | −3 711 | −6 229 | −4 671 | −3 862 | −3 056 | −5 584 | −7 058 | −8 831 | −7 781 |
| Depreciation & amort. | −0 | −6 | −107 | −172 | −244 | −257 | −310 | −417 | −387 | −332 |
| EBIT | −374 | −3 717 | −6 336 | −4 843 | −4 106 | −3 313 | −5 894 | −7 475 | −9 218 | −8 113 |
| Net financials | −11 | −4 | — | 54 920 | −1 | −61 | −44 | −54 | −138 | −146 |
| Profit before tax | −373 | −3 721 | −6 336 | 50 078 | −4 107 | −3 374 | −5 938 | −7 530 | −9 356 | −8 259 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −373 | −3 721 | −6 336 | 50 078 | −4 107 | −3 374 | −5 938 | −7 530 | −9 356 | −8 259 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 220 | 2 163 | 5 315 | 54 900 | 5 523 | 5 171 | 10 842 | 11 002 | 13 840 | 9 852 |
| Equity | 1 204 | 1 123 | 2 975 | 53 437 | 3 209 | 1 971 | 3 689 | 2 597 | 5 056 | 4 538 |
| Long-term debt | 27 | 0 | 0 | 0 | 0 | 0 | 813 | 903 | 924 | 479 |
| Short-term debt | 989 | 1 040 | 2 340 | 1 462 | 2 314 | 3 200 | 6 340 | 7 503 | 7 861 | 4 835 |
| Total debt | 1 016 | 1 040 | 2 340 | 1 462 | 2 314 | 3 200 | 7 153 | 8 406 | 8 785 | 5 314 |
EBITDA margin
-63.9%
This company
15.8%
Market median
-504% vs market
20152024
Equity ratio
46.1%
This company
38.2%
Market median
+21% vs market
20152024
Return on equity
-182.0%
This company
18.4%
Market median
-1089% vs market
20152024
Net profit margin
-67.8%
This company
8.1%
Market median
-937% vs market
20152024
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
20152024
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AJ Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
CB Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
JF Chief Auditor | Chief Auditor | 2020 | — | — |
CH Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Immuneed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Josef Kele | Chief Executive Officer | 0 companies |
| Camilla Birgitta Jansdotter Oldgren | Chief Executive Officer | 0 companies |
| Jonas Fredrik Mårtensson | Chief Auditor | 0 companies |
| Charlotte Hilda Helena Leife | Chief Executive Officer | 0 companies |
| Anna-Karin Elisabet Ekberg | Board of Directors | 0 companies |
| Mårten Winge | Board of Directors | 0 companies |
| Tor Jörgen Lönngren | Board of Directors | 0 companies |
| Philippe Paul G Stas | Chairman | 0 companies |
| Bengt Håkan Englund | Board of Directors | 0 companies |
| Fredrik Malmström | Deputy Board Member | 0 companies |
| Sara Maria Mangsbo | Deputy Board Member | 0 companies |
| Karin Marianne Hansson | Board of Directors | 0 companies |
| Per Fredrik Lehmann | Board of Directors | 0 companies |
| Carl Magnus Berthold Gustafsson | Board of Directors | 0 companies |
| Sven Fredrik Yngve Frejd | Board of Directors | 0 companies |
| Thomas Henrik Tötterman | Board of Directors | 0 companies |
| Anne Camilla Huse Bondesson | Chairman | 0 companies |